IP Library › Granted Patent US 9,579,186
Granted Patent B2
US 9,579,186 · App. 14/749,221 · Granted Feb 28, 2017

Medical devices and methods to prevent bile reflux after bariatric procedures

Inventors: John A. Hingston (Framingham, MA); Claude O. Clerc (Marlborough, MA); Jonathan Root (Groveland, MA); Vishal Shah (Whitehall, PA)
Assignee: BOSTON SCIENTIFIC SCIMED, INC.
A61F2/04A61F2/82A61M39/24A61F2/07A61F2/2475A61F2002/041A61F2002/044A61F2002/045A61F2250/0039A61M2039/2433
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,579,186
App. No.
14/749,221
Granted
Feb 28, 2017
Kind
B2
Abstract

An endoscopic stent for implantation in a patient after sleeve gastrectomy or biliopancreatic diversion with duodenal switch or biliopancreatic diversion with duodenal switch comprising a stent portion, the stent portion comprising a proximal end portion, the proximal end portion defined by a length of about 50 mm to about 200 mm, an enlarged middle portion, a middle portion having an enlarged diameter relative to the proximal end portion and the distal end portion and defined by a length of about 20 mm to about 80 mm, and a distal end portion and a polymeric sleeve portion engaged to and extending distally from the distal end portion of the stent.

Claims (25)

1. An endoscopic stent for implantation in portions of a patient's esophagus, stomach, and duodenum after sleeve gastrectomy or biliopancreatic diversion with duodenal switch or biliopancreatic diversion with duodenal switch, the endoscopic stent comprising:

a stent portion, the stent portion comprising a proximal end portion, a distal end portion, and an enlarged middle portion located between the proximal and distal end portions, wherein the proximal end portion is defined by a length of about 50 mm to about 200 mm, wherein the enlarged middle portion is defined by a length of about 20 mm to about 80 mm, and wherein the enlarged middle portion has an enlarged diameter relative to both the proximal end portion and the distal end portion; and

a polymeric cover disposed over the stent portion and extending distally beyond the distal end portion forming a polymeric sleeve portion, the polymeric sleeve portion devoid of stent material;

wherein the endoscopic stent is constructed and arranged for implantation such that the proximal end portion extends into a distal portion of the esophagus, the enlarged middle portion is disposed with a central portion of the stomach, the distal end portion terminates in the stomach, and only the polymeric sleeve portion extends into the duodenum.

2. The endoscopic stent of claim 1 , wherein the distal end portion is defined by a length of 0 mm to about 100 mm.

3. The endoscopic stent of claim 2 , wherein the distal end portion of the stent is about 50 mm to about 100 mm.

4. The endoscopic stent of claim 1 , wherein a proximal end of the proximal end portion, the distal end portion, or both, comprises a flare.

5. The endoscopic stent of claim 1 , wherein the polymeric sleeve portion is defined by a length of about 200 mm to about 350 mm.

6. The endoscopic stent of claim 1 , wherein the polymeric sleeve portion is elastomeric.

7. The endoscopic stent of claim 1 , wherein the polymeric sleeve portion comprises silicone.

8. The endoscopic stent of claim 1 , wherein the stent portion is braided, woven or laser cut.

9. The endoscopic stent of claim 1 , wherein the stent portion comprises nickel-titanium alloy, cobalt-chromium-nickel alloy, cobalt-chromium alloy, or stainless steel.

10. The endoscopic stent of claim 1 , wherein the polymeric sleeve portion is configured to collapse upon itself.

11. The endoscopic stent of claim 1 , further comprising a valve positioned in the distal end portion.

12. An endoscopic stent for implantation in a patient after sleeve gastrectomy or biliopancreatic diversion with duodenal switch, the endoscopic stent comprising:

a stent portion, the stent portion comprising a proximal end portion, the proximal end portion defined by a length of about 100 mm to about 200 mm, an enlarged middle portion, the enlarged middle portion having an enlarged diameter and defined by a length of about 40 mm to about 80 mm, and a distal end portion, the distal end portion defined by a length of about 50 mm to about 100 mm; and

wherein at least a portion of the distal end portion of the stent comprises reduced radial strength and is configured to extend across the pyloric valve and allow the pyloric valve to open and close;

wherein at least a portion of the distal end portion comprises a reduced wire diameter compared to the proximal end portion and middle portion, a lower braid angle compared to the proximal end portion and middle portion, or a reduced number of wires compared to the proximal end portion and middle portion, thereby achieving the reduced radial strength.

13. The endoscopic stent of claim 12 , wherein the proximal end portion, the distal end portion, or both, comprises a flare.

14. The endoscopic stent of claim 12 , wherein the endoscopic stent is woven, braided or laser cut.

15. The endoscopic stent of claim 12 , wherein the distal end portion of the endoscopic stent comprises a continuous wall configuration.

16. An endoscopic stent for implantation in a patient after sleeve gastrectomy or biliopancreatic diversion with duodenal switch, the endoscopic stent comprising:

a stent portion, the stent portion comprising a proximal end portion, the proximal end portion defined by a length of about 100 mm to about 200 mm, an enlarged middle portion, the enlarged middle portion having an enlarged diameter and defined by a length of about 40 mm to about 80 mm, and a distal end portion, the distal end portion defined by a length of about 50 mm to about 100 mm; and

an elastomeric band surrounding the distal end portion, the elastomeric band configured to apply an inward pressure to close a lumen extending through the stent porion;

wherein at least a portion of the distal end portion of the stent comprises reduced radial strength and is configured to extend across the pyloric valve and allow the pyloric valve to open and close.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 13, 2015
From: HINGSTON, JOHN A.; CLERC, CLAUDE O.; ROOT, JONATHAN; SHAH, VISHAL
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 036067/0682 →
Continuity (2)
Provisional Application 62017595 · Jun 26, 2014
Related Publication 20150374484A1 · Dec 31, 2015